Newman, Edward M
Mayo Clinic
Department of Medical Oncology, Division of Molecular Pharmacology, City of Hope, Duarte, CA, USA.
Citations 1
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies
Siddiqi, Tanya , Frankel, Paul , Kiesel, Brian F. , Christner, Susan M., Ruel, Chris , Song, Joo Y. , Chen, Robert , Kelly, Kevin R. , Kaesberg, Paul, Popplewell, Leslie , Puverel, Sandrine , Forman, Stephen J. , Newman, Edward M. , Song, Joo Y , Puverel, Sandrine , Newman, Edward M , Siddiqi, Tanya , Beumer, Jan Hendrik , Ailawadhi, Sikander , Piekarz, Richard
Leukemia & Lymphoma | October 16, 2019 | Volume: 61 | Issue: 2 | Pages: 309-317
